Loading clinical trials...
Loading clinical trials...
The purpose of the study is to conduct research of a new PET radiopharmaceutical in cancer patients. The uptake of the novel radiopharmaceutical 18F-FPPRGD2 will be assessed in study participants with...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Sanjiv Sam Gambhir
Collaborators
NCT02613988 · Adult Glioblastoma
NCT02186509 · Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma, and more
NCT01894061 · Adult Giant Cell Glioblastoma, Adult Glioblastoma, and more
NCT00662506 · Adult Giant Cell Glioblastoma, Adult Glioblastoma, and more
NCT01730950 · Adult Giant Cell Glioblastoma, Adult Glioblastoma, and more
Stanford University, School of Medicine
Stanford, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions